Search Results

There are 545 results for: content related to: rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy

  1. Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy

    Liver International

    Volume 35, Issue 11, November 2015, Pages: 2370–2383, Young E. Chon, Bora Jin, Sang H. Ahn, Seungtaek Kim, Nam D. Kim, Jeon H. Park, Chung M. Nam, Kyun-Hwan Kim, Sun P. Hong, Sung H. Choi, Do Y. Kim, Jun Y. Park and Kwang-Hyub Han

    Version of Record online : 13 MAY 2015, DOI: 10.1111/liv.12845

  2. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 55–64, Soon Sun Kim, Sung Won Cho, Soo-Ok Kim, Sun Pyo Hong and Jae Youn Cheong

    Version of Record online : 23 OCT 2012, DOI: 10.1002/jmv.23440

  3. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy

    Liver International

    Volume 29, Issue 4, April 2009, Pages: 552–556, Yoon-Seon Lee, Young-Hwa Chung, Jeong A. Kim, Sung Eun Kim, Jung Woo Shin, Kang Mo Kim, Young-Suk Lim, Neung Hwa Park, Han Chu Lee, Yung Sang Lee and Dong Jin Suh

    Version of Record online : 29 SEP 2008, DOI: 10.1111/j.1478-3231.2008.01882.x

  4. The influence of YMDD mutation patterns on clinical outcomes in patients with adefovir add-on lamivudine combination treatment

    Liver International

    Volume 32, Issue 2, February 2012, Pages: 303–310, Hong J. Kim, Jung H. Park, Dong I. Park, Yong K. Cho, Chong I. Sohn, Woo K. Jeon and Byung I. Kim

    Version of Record online : 14 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02647.x

  5. Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: Hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern

    Journal of Medical Virology

    Volume 82, Issue 11, November 2010, Pages: 1850–1858, Hans Damerow, Lilly Yuen, Johannes Wiegand, Christine Walker, C.-Thomas Bock, Stephen Locarnini and Hans L. Tillmann

    Version of Record online : 17 SEP 2010, DOI: 10.1002/jmv.21902

  6. Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF

    Journal of Medical Virology

    Volume 86, Issue 9, September 2014, Pages: 1473–1481, Yang Liu, Scott Fung, Edward J. Gane, Phillip Dinh, John F. Flaherty, Evguenia S. Svarovskaia, Michael D. Miller and Kathryn M. Kitrinos

    Version of Record online : 23 MAY 2014, DOI: 10.1002/jmv.23982

  7. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy

    Hepatology Research

    Volume 38, Issue 2, February 2008, Pages: 132–140, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1872-034X.2007.00144.x

  8. Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients

    Journal of Viral Hepatitis

    Volume 12, Issue 1, January 2005, Pages: 67–73, C. E. Westland, H. Yang, W. E. Delaney IV, M. Wulfsohn, N. Lama, C. S. Gibbs, M. D. Miller, J. Fry, C. L. Brosgart, E. R. Schiff and S. Xiong

    Version of Record online : 17 JAN 2005, DOI: 10.1111/j.1365-2893.2005.00578.x

  9. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates

    Journal of Medical Virology

    Volume 85, Issue 5, May 2013, Pages: 775–779, Maria Neumann-Fraune, Bastian Beggel, Herbert Pfister, Rolf Kaiser and Jens Verheyen

    Version of Record online : 13 FEB 2013, DOI: 10.1002/jmv.23530

  10. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e29–e39, Y. Liu, C. Wang, Y. Zhong, X. Li, J. Dai, X. Ren, Z. Xu, L. Li, Z. Yao, D. Ji, L. Wang, L. Zhang, V. W. -S. Wong, F. Zoulim and D. Xu

    Version of Record online : 6 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01360.x

  11. You have free access to this content
    Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

    Hepatology

    Volume 47, Issue 5, May 2008, Pages: 1473–1482, Carl J. Baldick, Daniel J. Tenney, Charles E. Mazzucco, Betsy J. Eggers, Ronald E. Rose, Kevin A. Pokornowski, Cheng F. Yu and Richard J. Colonno

    Version of Record online : 14 JAN 2008, DOI: 10.1002/hep.22211

  12. You have free access to this content
    HBV Virology and Diagnostics

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 705A–730A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26857

  13. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 26–33, Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low, Kieron Lim, Maung Aye Thwin, Poh Seng Tan and Seng Gee Lim

    Version of Record online : 28 SEP 2012, DOI: 10.1002/jmv.23392

  14. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 8, August 2014, Pages: e55–e64, Chien-Hung Chen, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu and Chuan-Mo Lee

    Version of Record online : 28 APR 2014, DOI: 10.1111/jvh.12239

  15. Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites

    Hepatology Research

    Volume 41, Issue 11, November 2011, Pages: 1017–1024, Lihui Deng and Hong Tang

    Version of Record online : 15 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00873.x

  16. Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy

    Hepatology Research

    Volume 39, Issue 1, January 2009, Pages: 14–20, Ri-Cheng Mao, You-Kuan Yin, Yan-Li Qin, Xiang-Hui Wu, Xin-Hua Weng, Ji-Ming Zhang and Mengji Lu

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1872-034X.2008.00411.x

  17. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains

    Journal of Viral Hepatitis

    Volume 18, Issue 11, November 2011, Pages: 804–814, S. Amini-Bavil-Olyaee, U. Herbers, T. Luedde, C. Trautwein and F. Tacke

    Version of Record online : 30 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01378.x

  18. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China

    Journal of Medical Virology

    Volume 84, Issue 2, February 2012, Pages: 207–216, Xiao-Guang Li, Bao-Ming Liu, Jie Xu, Xue-En Liu, Hai Ding and Tong Li

    Version of Record online : 14 DEC 2011, DOI: 10.1002/jmv.23182

  19. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains

    Journal of Medical Virology

    Volume 84, Issue 10, October 2012, Pages: 1558–1561, Qingzhou Luo, Yandan Zhong, Yongfeng Yang, Qingfang Xiong, Zhiliang Hu, Weiming Lu, Ping Huang and Ning Zhang

    Version of Record online : 15 AUG 2012, DOI: 10.1002/jmv.23369

  20. You have free access to this content
    Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

    HIV Medicine

    Volume 10, Issue 4, April 2009, Pages: 229–235, J Audsley, N Arrifin, LKW Yuen, A Ayres, SM Crowe, A Bartholomeusz, SA Locarnini, A Mijch, SR Lewin and J Sasadeusz

    Version of Record online : 28 JAN 2009, DOI: 10.1111/j.1468-1293.2008.00675.x